ArticleJournal of translational medicine2022

The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulation.

Hoang Oanh Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.